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A single dipeptide sequence modulates the redox properties of a
whole enzyme family
Martina Huber-Wunderlich and Rudi Glockshuber
Background: Disulfide exchange reactions are catalyzed by thiol/disulfide
oxidoreductases. These enzymes possess a thioredoxin fold and contain a
catalytic disulfide with the sequence Cys–X–X–Cys at the N terminus of an
α helix. Despite these similarities, the various members differ strongly in their
redox potentials (–122 mV to –270 mV). Using the strong oxidant DsbA from
Escherichia coli as a model system, we investigated whether the redox
properties of these enzymes can be modulated rationally by exchange of the
X–X dipeptide.
Results: The X–X dipeptide of DsbA (Cys30–Pro31–His32–Cys33) was
exchanged by the dipeptides of eukaryotic protein disulfide isomerase (PDI;
Gly–His), glutaredoxin (Pro–Tyr), and thioredoxin (Gly–Pro) from E. coli. All
variants were less oxidizing than wild-type DsbA and their redox potentials 
were in the order of the related natural enzymes (DsbA > PDI > glutaredoxin >
thioredoxin). The equilibrium constant between glutathione and the
thioredoxin-like variant increased 1200-fold compared with wild-type DsbA. The
variants also showed a strong increase in the pKa of the nucleophilic cysteine
(Cys30). As for glutaredoxin and thioredoxin, the catalytic disulfide stabilized
the corresponding variants while destabilizing wild-type DsbA and the 
PDI-like variant.
Conclusions: The X–X dipeptide in the active site of thiol/disulfide
oxidoreductases appears to be the main determinant of the redox properties of
these enzymes. This empirical finding should be very useful for the design of
new thiol/disulfide oxidoreductases with altered redox potentials and for
studying the function of these enzymes in vivo.
Introduction
DsbA from the periplasm of Escherichia coli was identified
as the first bacterial protein required for disulfide-bond for-
mation in vivo [1,2]. DsbA is a monomer of 189 amino acids
and contains a single, catalytic disulfide bond and the
active-site sequence Cys30–Pro31–His32–Cys33 [1,2]. The
enzyme randomly oxidizes folding polypeptides by disul-
fide exchange with substrate proteins [3–9] and is recycled
as an oxidant by the inner membrane protein DsbB
[10–13]. The high-resolution X-ray structure of oxidized
DsbA revealed that the enzyme consists of two domains
[14,15]. The fold of the catalytic domain (residues 1–62
and 139–189) is very similar to that of thioredoxin, the pro-
totype of the thiol/disulfide oxidoreductase family, but
shares only 10% sequence identity with thioredoxin from
E. coli [16]. The other DsbA domain (residues 63–138) is
inserted into the thioredoxin motif and exclusively consists
of α helices. Its function is presently unknown.
As in all structures of thiol/disulfide oxidoreductases — for
example, E. coli and human thioredoxin, E. coli and T4
glutaredoxin, porcine thioltransferase, and the catalytic
a-domain of human protein disulfide isomerase (PDI;
[17–26]) — the catalytic disulfide of DsbA is located at the
N terminus of an α helix. Only the N-terminal cysteine
(Cys30) is solvent exposed and capable of forming mixed
disulfides with substrates while Cys33 is buried [7,15,27,28].
Despite their structural similarities, the redox potentials
(Eo′) of the individual enzymes vary strongly (–122 mV to
–270 mV; cf. Table 1; [29–32]; the values of Eo′ given in
this paper refer to a redox potential of –240 mV for the
glutathione redox couple [33]). The cytoplasmic enzymes
thioredoxin and glutaredoxin are supposed to act as reduc-
tants, whereas PDI from the endoplasmic reticulum (ER)
of eukaryotes and DsbA from the bacterial periplasm are
strong oxidants that catalyze disulfide-bond formation in
secretory proteins. Intriguingly, the high-resolution X-ray
structures of oxidized DsbA [14,15] and oxidized thiore-
doxin [17], the strongest oxidant and the strongest reduc-
tant of the enzyme family, respectively, do not reveal
significant differences in the conformation of the poly-
peptide chain in the active-site region that could explain
the enormous differences in redox potentials (Figure 1).
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Importantly, studies on DsbA [34–37], thioredoxin [30,32,
38,39] and the a-domain of PDI [40] have shown that the
pKa value of the nucleophilic, N-terminal cysteine thiol of
the Cys–X–X–Cys motif is a critical factor for the redox
properties of disulfide isomerases (X corresponds to any
amino acid). Compared with the normal pKa of a cys-
teine thiol (≈9.5), the pKa of the nucleophilic cysteine is
extremely low in reduced DsbA (3.2–3.5; [34–37]), PDI
(4.5; [40]) and thioltransferase (3.5; [41,42]) and also
lowered in thioredoxins (7.1–7.4; [32,38,39]). In DsbA, the
low pKa of Cys30 (3.5) qualitatively explains that reduced
DsbA is more stable than oxidized DsbA at neutral pH
[27,43] because a stabilizing thiolate is removed upon for-
mation of the active-site disulfide [34]. In addition, the
Brønsted theory on disulfide exchange reactions [34,44]
predicts that the low pKa of Cys30 causes both the
extremely rapid disulfide exchange reactions involving
DsbA [4,27] and its low equilibrium constant with gluta-
thione [34,35]. Thus, there is a theoretical inter-relation
between the abnormal pKa of the nucleophilic thiol, the
microscopic rate constants for disulfide exchange reactions
of thiol/disulfide oxidoreductases, and the difference in
thermodynamic stability between the oxidized and reduced
forms of the enzymes.
It is generally believed that it is mainly the dipole of the
active-site helix that stabilizes the negative charge of the
N-terminal, nucleophilic thiolate of thiol/disulfide oxi-
doreductases [34,35,39,40,45,46]. This view is supported
by the lack of positively charged residues in the vicinity
of the active-site helix of DsbA that could favourably
interact with the Cys30 thiolate [15,47]. Besides the
structural context in the individual proteins, the amino-
acid sequences of the active-site helices and, in particular,
the X–X dipeptide sequences are a likely factor for deter-
mining the physico-chemical properties of thiol/disulfide
oxidoreductases. Several recent experiments support this
view. Holmgren and coworkers [48] first showed that a
thioredoxin variant with the X–X dipeptide of PDI has a
redox potential increased by 35 mV towards that of PDI.
Analogous results were then obtained for a PDI variant
with the dipeptide of thioredoxin, whose redox potential
decreased by 68 mV [40]. Random mutagenesis of the
X–X dipeptide in DsbA [35], thioredoxin [30] and PDI
[49] has also shown that the X–X dipeptide has a strong
influence on the redox properties of these enzymes.
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Figure 1
Comparison of the active-site regions in the high-resolution X-ray
structures of oxidized DsbA (red; residues 29–35; [15]) and oxidized
thioredoxin (blue; residues 31–37; [17]) from Escherichia coli. All
heavy backbone atoms and all sidechain atoms of the Cys–X–X–Cys
regions are shown. The superposition is based on the backbone atoms
of the segment Cys30–Pro31–His32–Cys33 of DsbA and the
segment Cys32–Gly33–Pro34–Cys35 of thioredoxin. Because both
DsbA and thioredoxin crystallize as asymmetric dimers, the structure of
each monomer is shown. The sulfur atoms of the active-site cysteines
are displayed as balls. The figure was generated with the program
MOLMOL [82]. X, any amino acid.
Table 1
Redox properties and pKa values of the thiol of Cys30 of wild-type DsbA and the active-site variants.
pKa Keq Eo′DsbA Eo′ of the corresponding
Dipeptide of Cys30 (M) (V) natural enzyme (V)
Wild-type DsbA (Pro–His) 3.28 ± 0.09 1.2 × 10–4 ± 4.7 × 10–6 –0.122 –0.122
Pro–Gly 4.85 ± 0.03 5.9 × 10–4 ± 1.7 × 10–5 –0.143 –
PDI type (Gly–His) 3.71 ± 0.05 7.3 × 10–4 ± 1.2 × 10–5 –0.146 –0.147/–0.159*
TR type (Ala–Thr) 4.34 ± 0.03 1.4 × 10–3 ± 1.9 × 10–5 –0.154 –0.25/–0.28†
Grx type (Pro–Tyr) 3.75 ± 0.06 1.8 × 10–3 ± 2.6 × 10–5 –0.157 –0.198/–0.233‡
Trx type (Gly–Pro) 6.21 ± 0.04 1.4 × 10–1 ± 1.4 × 10–3 –0.214 –0.270§
The equilibrium constants (Keq) were determined by fitting the original
data (Figure 2) according to Equation 2 (see the Materials and
methods section) and the standard redox potentials (Eo′ DsbA) of the
proteins were calculated according to Equation 4 with a value of
–0.240 V for the redox potential of the GSH/GSSG (reduced and
oxidized glutathione, respectively) redox couple [33]. The pKa value of
Cys30 was determined at 30°C as described in the legend of Figure 4.
*The values were calculated from the equilibrium constants of the
a-domain and a′-domain of PDI with glutathione at pH 7.5 [76,77].
†Note that TR does not possess the thioredoxin fold [78,79]. ‡Values
for glutaredoxin 1 and glutaredoxin 3, which have the same dipeptide
(Pro–Tyr; [67]). §See [32,48,80,81]. PDI, protein disulfide isomerase;
TR, thioredoxin reductase; Grx, glutaredoxin; and Trx, thioredoxin.
Here, we present the first systematic study on the general
role of the X–X dipeptide sequence using DsbA, the most
oxidizing thiol/disulfide oxidoreductase, as a model system.
We have replaced the Pro–His dipeptide in wild-type DsbA
(Eo′ = –122 mV) with the dipeptides of the more reducing
enzymes PDI (Gly–His), glutaredoxin (Pro–Tyr) and
thioredoxin (Gly–Pro; Table 1). To study the involvement
of the proposed electrostatic interaction between His32
and the Cys30 thiolate [40,45–47], we have performed the
replacement Pro–His→Pro–Gly. In addition, we have
introduced the X–X sequence of E. coli thioredoxin reduc-
tase (TR; Ala–Thr; the active site of TR mediates the
reduction of thioredoxin by reduced β-nicotinamide aden-
ine dinucleotide phosphate, NADPH, and has a Cys–X–
X–Cys motif [50] but no thioredoxin fold). We show that
the redox potentials of the PDI-like, glutaredoxin-like
and thioredoxin-like DsbA variants are shifted according
to those of the natural enzymes and that exchanges in
the X–X dipeptide sequence can generally be used to
rationally modulate the redox properties of these enzymes.
In addition, we analyze the inter-relation between the
redox potentials, Cys30 pKa values and the thermodynamic
stabilities of the oxidized and reduced variants.
Results
Purification and spectroscopic properties of DsbA variants
Wild-type DsbA and its variants were purified from peri-
plasmic extracts by anion exchange chromatography on
DE52 cellulose, hydrophobic chromatography on Phenyl
Sepharose, and cation exchange chromatography on CM52
cellulose. The yields of the purified, oxidized proteins
varied from 10 mg to 25 mg of DsbA per litre of bacterial
culture.
Wild-type DsbA shows a characteristic 3.4-fold increase in
tryptophan fluorescence at 332 nm (λex = 295 nm) upon
reduction of the active-site disulfide bridge [51], which is
due to a long-range, dynamic quenching of the fluores-
cence of Trp76 by the disulfide bond [52]. The tryptophan
fluorescence spectra of the oxidized and reduced dipeptide
variants were indistinguishable from the spectra of the wild
type (data not shown). 
The far-UV and near-UV CD spectra of the oxidized and
reduced variants at neutral pH also coincided with those of
wild-type DsbA (data not shown). Thus, the tertiary struc-
tures of all dipeptide variants are very similar to the struc-
tures of oxidized and reduced wild-type DsbA and the
amino acid replacements did not influence the global fold.
Equilibrium constants with glutathione and redox
potentials of DsbA dipeptide variants
The Eo′ values for the DsbA variants were determined by
measuring their equilibrium constants (Keq) with gluta-
thione at pH 7.0 and 30°C, using a value of –240 mV for
the redox potential of the glutathione redox couple [33].
Wild-type DsbA and the variants were incubated with dif-
ferent glutathione redox buffers, and the redox state of
the proteins at equilibrium was measured by their specific
tryptophan fluorescence, assuming no significant concen-
trations of DsbA–glutathione mixed disulfides at equilib-
rium [51]. We observed dramatic changes in Keq for the
DsbA variants. All proteins with X–X dipeptides of other
thiol/disulfide oxidoreductases showed a decreased redox
potential compared with wild-type DsbA, having the same
order of redox potential as the related natural enzymes
(i.e. wild type > PDI type > glutaredoxin type > thiore-
doxin type; Table 1 and Figure 2). The most reducing
variant, the thioredoxin-like variant, showed a 1200-fold
increased equilibrium constant compared with wild-type
DsbA, corresponding to a decrease in redox potential of
92 mV. Thus, the redox properties of thiol/disulfide oxi-
doreductases seem to be mainly determined by the di-
peptide sequence between the active-site cysteines. The
redox potential differences were smaller for all DsbA vari-
ants compared with the differences between the natural
enzymes, however (Table 1), indicating that the redox
properties of these enzymes are also modulated by the
individual protein context. The variants with the dipep-
tide sequence Pro–Gly (removal of His32) and Ala–Thr
(TR type) were also less oxidizing than wild-type DsbA
(Table 1 and Figure 2). 
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Figure 2
Redox equilibria of wild-type DsbA and its active-site variants with
glutathione at pH 7.0 and 30°C. The fraction of reduced DsbA at
equilibrium was measured using the specific DsbA fluorescence at
332 nm (excitation at 280 nm). The original data were fitted according
to Equations 1–3 (see the Materials and methods section) and
normalized (solid lines). PDI, protein disulfide isomerase; TR,
thioredoxin reductase; Grx, glutaredoxin; and Trx, thioredoxin.
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Thermodynamic stabilities of the oxidized and reduced
DsbA variants
The oxidative force of wild-type DsbA is reflected by its
destabilizing disulfide bond [27,43], whereas the catalytic
disulfide is stabilizing in the reductant thioredoxin [53–55].
A thermodynamic cycle involving native and denatured-
reduced, and native and denatured-oxidized DsbA implies
a correlation between the values of ∆∆Gox/red and the
redox potentials of the variants [27,35,43,55]. Because all
X–X dipeptide variants of DsbA were more reducing than
the wild type, we expected an increased thermodynamic
stability of the oxidized form relative to the reduced form
in all DsbA variants. The thermodynamic stabilities of
the oxidized and the reduced proteins were measured
at pH 7.0 and 30°C by guanidinium chloride (GdmCl)
induced unfolding/refolding equilibria that were followed
fluorimetrically and analyzed according to the two-state
model of folding (Table 2 and Figure 3; [56,57]). Wild-
type DsbA and all variants showed cooperative and fully
reversible equilibrium transitions. Oxidized wild-type DsbA
is 14.8 kJ mol–1 less stable than the reduced form, and all
variants indeed showed a lowered stability difference
(∆∆Gox/red) between both redox states (Table 2). Remark-
ably, the situation was even reversed in the case of the
most reducing mutant proteins, the glutaredoxin-like and
thioredoxin-like variants, for which the reduced forms
are significantly less stable than the oxidized forms,
with ∆∆Gox/red values of –9.3 kJ mol–1 and –10.2 kJ mol–1
(Table 2 and Figure 3). Thus, the sequence of the X–X
dipeptide alone can already determine whether the cat-
alytic disulfide bridge is stabilizing or destabilizing in the
context of the DsbA fold. Overall, the X–X dipeptide
replacements mostly affected the stabilities of the oxi-
dized forms of the variants, whereas the stabilities of the
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Figure 3
GdmCl-dependent unfolding/refolding equilibria of oxidized and
reduced wild-type DsbA and the oxidized and reduced thioredoxin-like
variant (Gly–Pro) at pH 7.0 and 30°C. Unfolding and refolding of DsbA
was performed in 100 mM sodium phosphate, 1 mM EDTA, pH 7.0,
containing different concentrations of GdmCl. Samples of reduced
DsbA also contained 1 mM DTT. The transitions were measured
fluorimetrically by the relative change in the fluorescence intensities at
365 nm for oxidized DsbA and 325 nm for reduced DsbA (excitation at
280 nm). The fraction of native molecules at equilibrium was calculated
from the original data according to a two-state model of folding using a
six parameter fit [56,57].
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Table 2
Free energies of stabilization of oxidized and reduced wild-type DsbA and active-site dipeptide variants at pH 7.0 and 30°C.
Midpoint of transition Cooperativity ∆Gstab ∆∆Gox/red
Dipeptide Redox state (M GdmCl) (kJ mol–1 M–1 GdmCl) (kJ mol–1) (kJ mol–1)*
Wild-type DsbA (Pro–His) Oxidized 1.66 20.2 ± 0.7 –33.5 ± 1.2 14.8 ± 4.0
Reduced 2.14 22.6 ± 1.3 –48.3 ± 2.8
Pro–Gly Oxidized 1.68 25.0 ± 0.9 –42.0 ± 1.6 12.5 ± 3.0
Reduced 2.10 25.9 ± 0.7 –54.5 ± 1.4
TR type (Ala–Thr) Oxidized 1.99 25.3 ± 1.1 –50.4 ± 2.2 8.4 ± 5.3
Reduced 2.28 25.8 ± 1.4 –58.8 ± 3.1
PDI type (Gly–His) Oxidized 1.77 27.4 ± 0.8 –48.4 ± 1.5 6.1 ± 4.7
Reduced 2.06 26.4 ± 1.6 –54.5 ± 3.2
Grx type (Pro–Tyr) Oxidized 1.88 30.8 ± 2.3 –57.9 ± 4.4 –9.3 ± 6.4
Reduced 2.32 20.9 ± 0.9 –48.6 ± 2.0
Trx type (Gly–Pro) Oxidized 1.97 26.8 ± 1.2 –52.8 ± 2.4 –10.2 ± 4.0
Reduced 1.80 23.6 ± 0.9 –42.6 ± 1.6
All unfolding/refolding experiments were performed in 100 mM sodium
phosphate, 1 mM EDTA, pH 7.0 containing different concentrations of
GdmCl and were evaluated as described in the legend of Figure 3.
*A possible entropic contribution of the disulfide bond to the free
energy of the unfolded state was not considered.
reduced forms were altered to a much lower extent
(Table 2). The oxidized forms of the glutaredoxin-like and
thioredoxin-like variants showed the largest stability
changes having an increase in stability of 24.4 kJ mol–1 and
19.3 kJ mol–1, respectively. Interestingly, the reduced vari-
ants were also slightly more stable than the reduced wild
type, except for the thioredoxin-like variant (Table 2). The
observed stability changes of both redox forms of the vari-
ants relative to the oxidized and reduced wild-type DsbA
were caused by changes in both the cooperativities and
midpoints of the transitions (Table 2).
Oxidation of substrates by the dipeptide variants
DsbA preferably reacts with reduced, unfolded polypep-
tide substrates that are randomly oxidized by the enzyme,
which is presumably caused by a peptide binding site
[4–6,8,14] and is especially important for disulfide bond
formation at acidic pH [4,5]. To test whether the more
reducing active-site variants of DsbA showed slower oxida-
tion of thiol substrates, we measured their apparent rate
constants of oxidation of 1,4-dithio-DL-threitol (DTT) and
the reduced, unfolded thrombin inhibitor hirudin (65
residues, three disulfide bridges) at pH 4.0 and 30°C.
Table 3 shows that the rate constants indeed dropped
according to the lowered redox potentials of the variants
(i.e. wild type > PDI-type > glutaredoxin-type > thioredox-
in-type and match their relative redox properties. The
thioredoxin-like variant showed 40–60-fold decreased rate
constants compared to the wild type. The polypeptide
specificity of the variants, defined as the ratio of the appar-
ent second-order rate constants of the oxidation of hirudin
and the oxidation of DTT (khirudin/kDTT) was, however, not
affected by the X–X exchanges, indicating that these resi-
dues do not contribute to the presumed peptide binding
site of DsbA.
Values of pKa for the nucleophilic, active-site cysteine
(Cys30) in the DsbA variants
As the oxidative force of wild-type DsbA can also be
explained by the extremely low pKa value (≈3.5) of the
nucleophilic thiol of Cys30 [34,35], we expected increased
pKa values for all DsbA variants. We measured the pH-
dependence of the thiolate-specific absorbance at 240 nm
[34] to determine the pKa value of Cys30 in all variants,
using the corresponding oxidized protein as a reference.
As DsbA is denatured at pH < 2, the titrations were per-
formed in the range of pH 2–8. The pKa of Cys30 indeed
proved to be increased in all dipeptide variants compared
with the wild type (Figure 4). The most dramatic shift was
observed for the thioredoxin-like variant, with a pKa of 6.2
compared with 3.3 for the wild-type DsbA (Table 1).
Except for the Pro–Gly variant, the plot of the equilibrium
constants with glutathione (Keq) versus the Cys30 pKa
values showed a reasonable agreement of the experimen-
tal data with the correlation predicted from the theory of
Szajewski and Whitesides ([44]; Figure 5a).
Discussion
Influence of the X–X dipeptide on the redox properties of
DsbA dipeptide variants
Using the most oxidizing thiol/disulfide oxidoreductase
DsbA as a model system, we have systematically replaced
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Figure 4
Determination of the pKa of the thiol of Cys30 in wild-type DsbA and
its active-site variants at 30°C. The thiolate of Cys30 was detected by
its UV absorbance at 240 nm [34]. The oxidized proteins were used as
a reference. The transitions were fitted according to the Henderson–
Hasselbalch Equation and normalized (see the Materials and methods
section for details).
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Table 3
Apparent second-order rate constants (kapp) of the oxidation of
DTT and reduced, unfolded hirudin by the DsbA variants at
pH 4.0 and 30°C.
kapp (M–1 s–1)
Dipeptide DTT Hirudin khirudin/kDTT
Wild-type DsbA (Pro–His) 4.3 × 103 7.8 × 104 18.1
Pro–Gly 6.6 × 102 1.3 × 104 19.7
PDI type (Gly–His) 2.6 × 103 5.1 × 104 19.8
Grx type (Pro–Tyr) 4.2 × 102 9.5 × 103 22.6
Trx type (Gly–Pro) 72 1.9 × 103 26.4
The oxidized DsbA variants (2 µM) were mixed with stoichiometric
amounts of DTT (2 µM) or reduced, unfolded hirudin (0.67 µM) in
100 mM formic acid/NaOH pH 4.0, 200 mM KCl, 1 mM EDTA. The
reactions were followed fluorimetrically (λex = 295 nm, λem = 322 nm)
by the increase in tryptophan fluorescence caused by the generation of
reduced DsbA. The kinetics were evaluated according to an apparent
second-order dithiol/disulfide reaction with identical initial
concentrations (2 µM) of the reactants. DTT, 1,4-dithio-DL-threitol.
the X–X dipeptide between the active-site cysteines
against the dipeptides of the related, more reducing enz-
ymes. Importantly, not only were the redox potentials of
the DsbA variants shifted towards lower values, but the
order of redox potentials of the natural enzymes was also
retained for the DsbA variants. The X–X mutations alone
were for instance not sufficient to convert DsbA into an
enzyme as reducing as thioredoxin. The shifts in redox
potential were generally about half of the redox potential
difference of the corresponding natural enzymes (Table 1).
The same observation was made in a study on X–X variants
of the most reducing enzyme thioredoxin, which showed
analogous shifts to higher redox potentials when the dipep-
tide sequences of other thiol/disulfide oxidoreductases
were introduced [32,48]. Analogous results were reported
for the catalytic a-domain of PDI, in which the thioredoxin-
like mutation Gly–His→Gly–Pro led to a decrease in redox
potential by 68 mV [40], and for the TlpA protein from
Bradyrhizobium japonicum, whose redox potential increased
by 66 mV after the PDI-like dipeptide exchange, Val–Pro→
Val–His [58]. Thus, the rational exchange of the X–X
dipeptide generally should be applicable for the design of
thiol/disulfide oxidoreductases with certain redox proper-
ties and should be especially useful to study the function of
these enzymes in vivo.
The more reducing properties of the active-site dipeptide
variants correlated well with their lowered rates of oxida-
tion of thiol substrates. Because the most reducing thiore-
doxin-like variant showed a 40–60-fold lowered rate
constant compared with wild-type DsbA but a 1200-fold
increased equilibrium constant with glutathione, changes
of both the rate constants of oxidation and the rate con-
stants of reduction of DsbA appear to be responsible for
the overall changes in their equilibrium constants with
glutathione. The non-affected polypeptide specificity of
the variants agrees well with the fact that the dipeptide is
not part of the presumed peptide binding site in the X-ray
structure of oxidized DsbA [15].
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Figure 5
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Figure 5 continued
Correlation between the redox potentials, the pKa values of the thiol of
Cys30, and the thermodynamic stabilities for wild-type DsbA and the
active-site variants. (a) Correlation between the redox potentials and
the pKa values of Cys30. The experimentally measured values of the
equilibrium constants with glutathione (Keq; Table 1 and FIgure 1)
were plotted versus the pKa values of the thiol of Cys30 (Table 1 and
Figure 4). The dashed line represents the predicted relationship
between Keq and the pKa of Cys30 assuming pKa values of 9.0 and
8.7 for the thiols of Cys33 and glutathione, respectively [34,44].
(b) Correlation between the measured values of ∆∆Gox/red and those
predicted from the pKa values of Cys30. The pH dependence of
∆∆Gox/red was simulated according to Equation 12. The averaged
cooperativities (m-values) of the oxidized (25.8 kJ mol–1 M–1) and the
reduced (24.2 kJ mol–1 M–1) forms were used to calculate the
experimental data for ∆∆Gox/red, as all oxidized and all reduced variants
should have the same m-values [69]. Worse correlations were
obtained when the ∆∆Gox/red values calculated with non-averaged
m-values (cf. Table 2) were used. The dashed line represents the
diagonal. ∆∆∆Gox/red corresponds to ∆∆Gox/red (variant) – ∆∆Gox/red
(wild type). (c) Correlation between the measured equilibrium
constants with glutathione and those calculated from ∆∆∆Gox/red. To
predict ∆ln Keq from ∆∆∆Gox/red, the averaged cooperativities
(m-values) of the oxidized (25.8 kJ mol–1 M–1) and the reduced forms
(24.2 kJ mol–1 M–1) were used; see (b). ∆ln Keq corresponds to
ln Keq(variant) – ln Keq(wild type). The dashed line indicates where the
measured and calculated values of ∆ln Keq are equal.
Ionization of the nucleophilic, active-site thiol of Cys30 
Analysis of the X–X sequences reveals that two amino
acids in the X–X dipeptide may be especially important.
The conserved proline at the first position of the dipeptide
in DsbA appears to favour the electrostatic interaction of
the thiolate anion with the helix dipole, which recently has
been demonstrated for helical model peptides with the
sequence Cys–Pro at the N terminus [59]. In contrast, a
proline at the second position of the dipeptide is a charac-
teristic feature of thioredoxins, which are strong reductants.
In addition, a histidine at the second position of the dipep-
tide is conserved in the oxidants DsbA and PDI and
appears to stabilize the nucleophilic thiolate anion electro-
statically [15,40,46] and reduce its pKa value by about one
unit [40]. Overall, the stabilization of the nucleophilic thio-
late by hydrogen bonds [20,23] and its interaction with the
partial positive charge of the helix dipole [60–64] appear to
be the most important interactions that cause the extremely
low pKa values of the N-terminal, active-site cysteines
of thiol/disulfide oxidoreductases [34–37]. No positively
charged residues interact directly with the nucleophilic thio-
late in the known structures of reduced thioredoxin and
glutaredoxin [18–20,22,23,65,66], and elimination of all
charged residues in the vicinity of the active-site helix of
DsbA did not affect the pKa of Cys30 [37].
Correlation between the Cys30 pKa values of DsbA variants
and their redox properties
With the exception of the Pro–Gly variant, we found the
correlation that was expected between the Cys30 pKa
values of the DsbA variants and their equilibrium con-
stants with glutathione when a constant pKa of 9.0 for the
buried Cys33 was assumed within the framework of the
theory of Szajewski and Whitesides ([34,35,44]; Figure 5a).
Deviations form the theory may indeed be caused by an
influence of the X–X sequence on the pKa of the buried
active-site thiol, which is likely to be the case for the corre-
sponding variants of thioredoxin [32]. In addition, the indi-
vidual protein context is also important; this is underlined
by the 35 mV difference in redox potential between
glutaredoxin 1 and 3 from E. coli, which both have the
dipeptide Pro–Tyr [67]. The same is valid for DsbA from
E. coli and Vibrio cholerae, which have the dipeptide Pro–
His but different pKa values of the nucleophilic thiolate of
3.5 and 5.1, respectively [34,68].
Thermodynamic stabilities of oxidized and reduced DsbA
variants
In the structure of oxidized wild-type DsbA, both side-
chains of the X–X dipeptide are solvent exposed and are
not in direct contact with other residues [15]. Nevertheless,
the X–X variants of DsbA showed dramatic changes in
thermodynamic stabilities compared with wild-type DsbA.
The most unexpected finding is that the X–X exchanges
particularly affected the stabilities of the oxidized variants
because any increase in the pKa of Cys30 should decrease
the stability of reduced DsbA at pH 7.0, but the stability of
oxidized DsbA should essentially be unaffected [34,37].
The most extreme stability changes were observed for the
oxidized glutaredoxin-like and thioredoxin-like variants,
which were 24.4 kJ mol–1 and 19.3 kJ mol–1 more stable
than the oxidized wild-type DsbA (Table 2). The recently
solved X-ray structure of the oxidized, glutaredoxin-like
variant Pro–Tyr is, however, very similar to that of the oxi-
dized wild type and does not provide a simple explanation
of its dramatically increased stability [47]. Compared with
the oxidized wild type, the variant’s cooperativity of folding
(m-value) is strongly increased from 20.2 kJ mol–1 M–1 to
30.8 kJ mol–1 M–1 (Table 2), indicating residual structure in
unfolded, oxidized wild-type DsbA [69]. As the m-values of
the reduced proteins varied to a smaller extent (Table 2),
the disulfide bond in the oxidized protein may induce
residual structure in the unfolded proteins, and the X–X
sequence may modulate the extent of residual structure in
the oxidized, unfolded variants.
Inter-relation of redox potential, pKa of the nucleophilic
thiol and thermodynamic stability 
Assuming that oxidation of DsbA is nothing but the
removal of the negatively charged thiolate of Cys30, we
calculated the expected changes in the stability difference
between the oxidized and reduced form of all variants at
pH 7.0 compared with that of wild-type DsbA (∆∆∆Gox/red)
and found a reasonable agreement with the measured data,
except for the Pro–Gly dipeptide variant (Figure 5b). A rea-
sonable correlation was also obtained for the measured
equilibrium constants with glutathione and the stability
differences between the oxidized and reduced forms of
the proteins, ∆∆Gox/red (Figure 5c). Overall, the theoretical
interdependence of Keq values with glutathione, ∆∆Gox/red,
and the pKa of Cys30 could be confirmed qualitatively, with
the best correlation for the dependence of Keq on the pKa of
Cys30 (Figure 5a). Other DsbA variants with replacements
of charged residues in the vicinity of the active-site helix
were recently shown to lack a correlation between Keq and
the pKa of Cys30, however [37]. The molecular mecha-
nisms underlying the physical properties of DsbA are obvi-
ously more complex, and the correlation Keq versus pKa
essentially may be valid only for variants with replacements
in the active-site helix. Deviations may also result from
changes in the pKa of the buried Cys33, which was assumed
to be normal and not affected by the amino acid replace-
ments [34]. As the absorbance of DsbA at 240 nm changes
strongly at alkaline pH, the pKa of Cys33 could not be
determined accurately by absorbance measurements. Dif-
ferent residual structures in the unfolded variants and pKa-
independent changes of the reactivity of Cys30 in the
variants, as observed for variants of thioredoxin [32], are
other possible reasons for deviations from theory. In
summary, the physico-chemical properties of thiol/disulfide
oxidoreductases are determined largely by the X–X dipep-
tide in the active site. Amino acid replacements in this
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sequence obviously have a strong influence on the dipole of
the active-site helix which stabilizes the thiolate anion of
the nucleophilic cysteine.
In vivo function of thiol/disulfide oxidoreductases
Interestingly, strongly reducing X–X variants of DsbA gen-
erated by random mutagenesis have been shown to be bio-
logically active [35]. This raises the question of whether the
redox properties of DsbA are at all important for its function
in vivo. Because DsbA acts as a catalyst of disulfide transfer
from the inner membrane protein DsbB to the folding
polypeptide chain [10–13], presumably its in vivo function
will not be influenced by changes in redox potential as long
as the overall rate-limiting step of catalysis (i.e. oxidation of
the folding polypeptide or recycling of DsbA as an oxidant
is not affected significantly). The situation appears to be
different for thioredoxin and eukaryotic PDI, which are in a
stationary equilibrium with small redox compounds like
NADP+/NADPH and glutathione, respectively. Thus, the
ratio between oxidized and reduced PDI and oxidized and
reduced thioredoxin in the cell is regulated. If this ratio is
critical for the in vivo function of the enzymes, strong
changes in redox potential may lead to biologically inactive
proteins. In accordance, PDI deficiency in yeast could not
be complemented with E. coli thioredoxin, but with a thio-
redoxin variant with increased redox potential [30,31]. The
present study provides a rational tool to study the function
of thiol/disulfide oxidoreductases in vivo by mutant proteins
with altered redox properties.
Materials and methods
Materials
5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), 1,4-dithio-DL-threitol (DTT),
and reduced and oxidized glutathione (GSH and GSSG, respectively)
were from Sigma (Deisenhofen, Germany). GdmCl was purchased
from ICN Biochemicals (Ohio, USA). Glutathione reductase (EC
1.6.4.2) from yeast was obtained from Boehringer Mannheim
(Germany) and reduced NADPH was purchased from Fluka Biochem-
ica (Buchs, Switzerland). DE52 and CM52 cellulose were obtained
from Whatman (Maidstone, UK) and Phenyl Sepharose HP and PD10
columns were from Pharmacia (Uppsala, Sweden). HPLC-purified
oligonucleotides were purchased from MWG-Biotech (Ebersberg,
Germany). All other chemicals were from Merck (Darmstadt, Germany)
and of the highest purity available.
Cloning, expression and purification of DsbA variants
Molecular cloning techniques were based on Sambrook et al. [70]. Site-
directed mutagenesis of the X–X dipeptide of DsbA was carried out
according to Kunkel et al. [71] using uridinylated, single-stranded DNA of
the plasmid pRBI-PDI [72] and the following oligonucleotides (mis-
matches are in bold): Gly–His: 5′ CAGAAATATGCAGTACTTCTTC-
AAACTGATAGCAGTGACCGCAGAAGAAAGAG 3′; Pro–Tyr: 5′ CAG-
AAATATGCAGTACTTCTTCAAACTGATAGCAGTACGGGCAGAAGA-
AAGAG 3′; Pro–Gly: 5′ CTTCAAACTGATAGCAACCCGGGCAGAA-
GAAAGAG 3′; Gly–Pro: 5′ CAGAAATATGCAGTACTTCTTCAAACTG-
ATAGCACGGACCGCAGAAGAAAGAG 3′; and Ala–Thr: 5′CTTCAAA-
CTGATAGCACGTGGCGCAGAAGAAAGAGAAAAAC 3′. All mutations
were verified by sequencing of the whole DsbA genes.
Cells of the dsbA– strain JCB609 [1] harboring the corresponding
expression plasmids were used for overproduction of the DsbA vari-
ants. Growth of bacterial cultures and purification of the proteins from
the periplasm of E. coli by anion exchange chromatography on DE52,
hydrophobic chromatography on Phenyl Sepharose and cation
exchange chromatography on CM52 were performed as described
previously [36,51]. All preparations were ≥ 99% pure as judged by
Coomassie-stained SDS gels.
Protein concentration
The molecular mass of wild-type DsbA and each dipeptide variant was
confirmed by electrospray mass spectrometry (error ≤ 1 Da). The protein
concentrations of the variants were determined by their specific
absorbance at 280 nm (A280 nm, 1 cm, 1 mg ml–1 = 1.17 for the glutaredoxin-
like variant and 1.10 for wild-type DsbA and all other variants; [73]). Wild-
type DsbA and all dipeptide variants were completely oxidized after
purification as shown by Ellman’s assay (ε412nm = 13600 M–1 cm–1 per
free thiol; [74]).
Circular dichroism measurements
Far-UV and near-UV CD spectra were recorded at room temperature
on a Jasco J710 spectropolarimeter, accumulated 16 times for near-UV
and 32 times for far-UV spectra and corrected for the buffer. Proteins
(35 µM) were dissolved in 1 mM sodium phosphate, 10 mM sodium
sulfate, pH 7.0. Samples of reduced DsbA also contained 100 µM
DTT. 0.02 cm and 1 cm quartz cuvettes were used for the far-UV
(180–270 nm) and near-UV (250–350 nm) region, respectively.
Fluorescence spectra and redox equilibria with glutathione
Fluorescence experiments were performed on a Hitachi F-4500 and a
Perkin-Elmer MPF-3L fluorescence spectrometer at 30°C and protein
concentrations of 1 µM in 100 mM sodium phosphate, pH 7.0. The
redox state of DsbA in glutathione redox buffers was followed by the
change in fluorescence intensity at 332 nm (excitation wavelength
280 nm). Oxidized DsbA (1 µM) was incubated for 24 h at 30°C in
100 mM sodium phosphate, 1 mM EDTA, pH 7.0 containing 500 µM,
100 µM, 50 µM or 5 µM GSSG and different concentrations of GSH
(1 µM–15 mM). To exclude air oxidation, filtered buffer solutions (pore
size 0.2 µm) were degassed and flushed with nitrogen. Protein samples
were incubated under nitrogen atmosphere. The GSSG contamination
present in the GSH stock solution was quantified by reduction of
GSSG with NADPH using yeast glutathione reductase as a catalyst
[75]. The DsbA/glutathione equilibrium constant (Keq) was calculated
according to Equations 1–3:
(1)
(2)
(3)
where R is the fraction of reduced DsbA at equilibrium, F is the mea-
sured fluorescence intensity, and Fox and Fred are the fluorescence
intensities of completely oxidized and reduced DsbA, respectively.
Analysis of the normalized data fitted according to Equation 3 yielded
correlation coefficients ≥ 0.995 after nonlinear regression. The stan-
dard redox potential for DsbA was calculated with the Nernst Equation
(see Equation 4) using a value of –240 mV for the standard redox
potential of the GSH/GSSG redox couple (Eo′ GSH/GSSG; [33]).
Eo′DsbA = Eo′GSH/GSSG – (RT/2F) ln Keq (4)
Oxidation of thiol substrates by the DsbA variants
Reduced, unfolded hirudin (A280 nm, 1 cm, 1 mg ml–1 = 0.37) was prepared
as described previously [4]. To measure the kinetics of oxidation of
DTT and hirudin by wild-type DsbA and its variants, the oxidized pro-
teins (2 µM) were rapidly mixed with stoichiometric amounts of the thiol
substrates and the formation of reduced DsbA was determined fluori-
metrically by the increase in tryptophan fluorescence at 322 nm
(λex = 295 nm) as described [4].
R = [GSH] /[GSSG]
K +([GSH] /[GSSG])
2
eq
2
R =  
(F – F )
(F – F )
ox
red ox
F = F +
(F – F )([GSH] /[GSSG])
(K +([GSH] /[GSSG])
ox
red ox
2
eq
2
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Unfolding and refolding of DsbA
For unfolding experiments, the proteins (1.0 mg ml–1 in distilled water)
were diluted 1:50 with 100 mM sodium phosphate, 1 mM EDTA, pH 7.0
containing different concentrations of GdmCl and incubated at 30°C for
3 days. The reduced proteins were unfolded under identical conditions,
except that all solutions contained 1 mM DTT. Refolding experiments
were performed at the same conditions, using a stock solution of the
unfolded proteins in 6 M GdmCl. The transitions were measured fluori-
metrically by the change in the fluorescence at 365 nm for oxidized DsbA
and 325 nm for reduced DsbA (excitation at 280 nm). GdmCl concen-
trations were calculated from the refractive index of the solutions. For
calculation of ∆G values, a six-parameter fit was used [43,57].
Determination of the pKa value of Cys30 
The titration of the Cys30 thiol was followed by the thiolate-specific
absorbance increase at 240 nm [34]. All measurements were carried out
at 30°C in buffer A (10 mM K2HPO4, 10 mM boric acid, 10 mM sodium
succinate, 1 mM EDTA, 200 mM KCl, pH 8). The proteins (~150 µM)
were first reduced with 500 µM DTT in buffer A, and excess DTT was
removed by gel filtration on a PD10 column equilibrated with 100µM
2-mercaptoethanol in buffer A. The oxidized proteins were used as a ref-
erence and treated in the same way without reducing agents. For titration
experiments, 100 mM HCl was added stepwise to the protein solution
(~20 µM; initial volume 2 ml) in portions of 20–50 µl. The pH was mea-
sured directly in the cuvette using an Orion pH meter equipped with a
Hamilton Biotrode. The absorbance at 280 nm and 240 nm was
recorded on a Cary 3E UV-visible spectrophotometer for 10 s, averaged,
and corrected for the volume increase. As the absorbance of DsbA at
280 nm proved to be independent of pH, (A240red/A280red)/(A240ox/A280ox)
was used as a measure of the fraction of the Cys30 thiolate. The data
were fitted according to the Henderson–Hasselbalch equation.
Prediction of rate constants, equilibrium constants and
stability differences
The overall reaction between DsbA and glutathione is given by the
following equations:
(5)
(6)
(7)
Keq = KI KII (8)
where k1, k2, k3 and k4 are the microscopic rate constants for the four
individual disulfide exchange reactions. KI is the equilibrium constant
for the formation of the mixed disulfide between Cys30 and glu-
tathione, KII is the equilibrium constant for the formation of oxidized
protein from the mixed disulfide, and Keq is the overall equilibrium con-
stant for the oxidation of DsbA by glutathione. The second-order rate
constant of the reaction between a thiolate and a disulfide is related to
the pKa values of the nucleophilic (nuc), central (c) and leaving group
thiol (lg) by a Brønsted relationship according to Equation 9 [34,44]:
log k = 4.5 + 0.59 pKa(nuc) – 0.4 pKa(c) – 0.59 pKa(lg) (9)
Because only the thiolate anion acts as a nucleophile, the observed
second-order rate constant (kobs) of a thiol/disulfide exchange reaction
is dependent on pH according to Equation 10:
log kobs = log k – log [1 + 10(pKa (nuc) – pH)] (10)
The overall equilibrium constant for the reaction was then simulated
according to Equation 11.
(11)
For all simulations, a pKa value of 8.7 for the glutathione thiol was used
[44]. A constant pKa of 9.0 was assumed for the buried thiol of Cys33.
To predict differences between the thermodynamic stability of the oxi-
dized and reduced form of the variant (∆∆Gox/red), we used Equa-
tion 12, which assumes that oxidation of DsbA is nothing but the
removal of a stabilizing, negatively charged thiolate [37].
∆∆Gox/red(pH 7) = –RT ln[(1 + 107 – pKa(n))/(1 + 107 – pKa(u))] (12)
where pKa(n) and pKa(u) are the pKa values of Cys30 in native and
unfolded DsbA, respectively. pKa(u) was 9.0 in all calculations.
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